Literature DB >> 3145854

Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection.

J W van 't Wout1, I Linde, P C Leijh, R van Furth.   

Abstract

The aim of the present study was to investigate the contribution of granulocytes and monocytes to resistance against an acute systemic candidal infection in mice. To this end granulocytopenia and monocytopenia were induced by irradiation or treatment with cyclophosphamide, and monocytopenia was obtained by treatment with VP-16. After intravenous injection of 1 X 10(4) Candida albicans into mice irradiated with 8 GY, the number of Candida albicans cultured from the kidneys, expressed as the geometric mean of the number of CFU/g tissue, was 5.4 X 10(4), 7.1 X 10(6) and 5.8 X 10(7) on days 1, 3 and 5 of infection respectively (p less than 0.001 compared to normal mice). The number of Candida albicans cultured from the liver and spleen was also significantly higher for irradiated animals than for normal mice (p less than 0.001). For cyclophosphamide-treated mice the number of organisms in the kidney (1.7 X 10(4) CFU/g on day 1, 1.9 X 10(6) on day 3 and 3.8 X 10(6) on day 5 of infection) and spleen was significantly higher (p at least less than 0.02) than for normal mice after injection of 1 X 10(3) Candida albicans. Monocytopenia induced by VP-16 did not result in an increase in the number of Candida albicans cultured from the kidney or spleen after infection. From these studies it is concluded that granulocytes and not monocytes or exudate macrophages play an important role in resistance against Candida albicans during the first five days of a systemic infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3145854     DOI: 10.1007/bf01975039

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Disseminated candidiasis in leukopenic dogs.

Authors:  D V Ehrensaft; R B Epstein; S Sarpel; B R Andersen
Journal:  Proc Soc Exp Biol Med       Date:  1979-01

2.  Evidence for macrophage-mediated protection against lethal Candida albicans infection.

Authors:  F Bistoni; A Vecchiarelli; E Cenci; P Puccetti; P Marconi; A Cassone
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

3.  Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice.

Authors:  D K Giger; J E Domer; S A Moser; J T McQuitty
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Pulmonary clearance of Candida albicans in neutropenic mice.

Authors:  K M Nugent; J M Onofrio
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

5.  The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.

Authors:  R I Lehrer
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

6.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

7.  Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs.

Authors:  P G Sohnle; M M Frank; C H Kirkpatrick
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

8.  Candidiasis in cancer patients.

Authors:  G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

9.  Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection.

Authors:  B Hurtrel; P H Lagrange; J C Michel
Journal:  Ann Immunol (Paris)       Date:  1980 Jan-Feb

10.  Murine defense mechanism against Candida albicans infection. I. Collaboration of cell-mediated and humoral immunities in protection against systemic C. albicans infection.

Authors:  K Kagaya; T Shinoda; Y Fukazawa
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  25 in total

Review 1.  Thriving within the host: Candida spp. interactions with phagocytic cells.

Authors:  Pedro Miramón; Lydia Kasper; Bernhard Hube
Journal:  Med Microbiol Immunol       Date:  2013-01-25       Impact factor: 3.402

Review 2.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Identifying host immune effectors critical for protection against Candida albicans infections.

Authors:  Andrew Y Koh
Journal:  Virulence       Date:  2016-06-23       Impact factor: 5.882

5.  Gene expression in HL60 granulocytoids and human polymorphonuclear leukocytes exposed to Candida albicans.

Authors:  Alaka Mullick; Miria Elias; Penelope Harakidas; Anne Marcil; Malcolm Whiteway; Bing Ge; Thomas J Hudson; Antoine W Caron; Lucie Bourget; Serge Picard; Orce Jovcevski; Bernard Massie; David Y Thomas
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  No effect of recombinant human interleukin-1 on numbers of peripheral blood and peritoneal leukocytes during acute inflammation.

Authors:  B J Kullberg; J W Van't Wout; R van Furth
Journal:  Inflammation       Date:  1991-12       Impact factor: 4.092

7.  Adherence of Candida albicans to tissues from mice with genetic immunodeficiencies.

Authors:  D L Brawner; F O Smith; M Mori; S Nonoyama
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Interferon-gamma activates the oxidative killing of Candida albicans by human granulocytes.

Authors:  A Stevenhagen; R van Furth
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  In vitro study of contact-mediated killing of Candida albicans hyphae by activated murine peritoneal macrophages in a serum-free medium.

Authors:  T Hashimoto
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

10.  Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis.

Authors:  Lisa Y Ngo; Shinji Kasahara; Debra K Kumasaka; Sue E Knoblaugh; Anupam Jhingran; Tobias M Hohl
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.